Tapewire

NYSE · USD

MD

Pediatrix Medical Group, Inc.

Export transactions ↓
Tapewire entity
4451
SEC CIK
0000893949
Parsed reports
309

Last 12 months

Inside the activity.

0 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202501
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 01, 2017 Filed Jun 2, 2017 20:40 UTC GrantCommon Stock 2,292 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037303 · doc4.xml · nonDerivative · entry 1

FERNANDEZ MICHAEL · CIK 0001218838 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,239

F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 20:39 UTC
Clark David A.Pres. Mednax Natl Med Group
SaleCommon Stock 10,202 $54.99 $561,040.63
Disclosure

SEC source: 0001209191-17-037298 · doc4.xml · nonDerivative · entry 2

Clark David A. · CIK 0001443082 · Pres. Mednax Natl Med Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,100

F2 · kind: Sales made pursuant to Reporting Person's 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in fifty-three (53) separate transactions with prices ranging from $54.16 to $55.39 for an average weighted sales price of $54.9932. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 20:39 UTC
Clark David A.Pres. Mednax Natl Med Group
GrantCommon Stock 15,277 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037298 · doc4.xml · nonDerivative · entry 1

Clark David A. · CIK 0001443082 · Pres. Mednax Natl Med Group

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,302

F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The vesting of the restricted shares is subject to performance based criteria but will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 20:39 UTC GrantCommon Stock 2,292 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037292 · doc4.xml · nonDerivative · entry 1

WALDEMAR, MD CARLO A · CIK 0001218839 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,547

F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 20:37 UTC GrantCommon Stock 2,292 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037282 · doc4.xml · nonDerivative · entry 1

Barker Karey D · CIK 0001641573 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,012

F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 20:37 UTC
CALABRO JOSEPH MPresident and COO
SaleCommon Stock 23,327 $55.00 $1,282,933.68
Disclosure

SEC source: 0001209191-17-037286 · doc4.xml · nonDerivative · entry 2

CALABRO JOSEPH M · CIK 0001218834 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 262,784

F2 · kind: Sales made pursuant to Reporting Person's 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in sixty-four (64) separate transactions with prices ranging from $54.13 to $55.40 for an average weighted sales price of $54.9978. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4 · balance_after: Reflects a reduction of 10,268 in previously reported target restricted shares that were granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with achievement of specified performance-based criteria below target for the performance period from April 1, 2016 through March 31, 2017. The decrease in restricted shares impacts the installments vesting on June 1, 2017, June 1, 2018 and June 1, 2019. The vesting of such shares remains subject to continued employment.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 20:37 UTC
CALABRO JOSEPH MPresident and COO
GrantCommon Stock 67,398 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037286 · doc4.xml · nonDerivative · entry 1

CALABRO JOSEPH M · CIK 0001218834 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 296,379

F1 · shares: Restricted shares granted pursuant to the Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The number of shares being reported represents the "target" number of restricted shares and does not include the right of the reporting person to receive up to 16,849 additional shares based on the achievement of certain performance-based criteria for the period from April 1, 2017 through March 31, 2018. The actual number of shares earned could be less than or greater than the target number, depending on the level of performance achieved, and all of the restricted shares granted are subject to forfeiture if minimum levels of performance are not met. Any restricted shares earned will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 20:36 UTC
Andreano Dominic JSVP, General Counsel and Secy
GrantCommon Stock 8,987 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037278 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,216.22

F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. The vesting of the restricted shares is subject to performance based criteria but will not vest any earlier than in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020.

Read SEC document
June 01, 2017 Filed Jun 2, 2017 20:36 UTC GrantCommon Stock 2,292 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037277 · doc4.xml · nonDerivative · entry 1

ALVAREZ CESAR L · CIK 0001220297 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,547

F1 · shares: Restricted shares granted pursuant to Issuer's Amended and Restated 2008 Incentive Compensation Plan, as amended, in connection with annual equity award. Shares will vest in three equal installments on June 1, 2018, June 1, 2019 and June 1, 2020.

Read SEC document
May 05, 2017 Filed May 8, 2017 20:29 UTC
Lopez-Blanco VivianChief Financial Officer
SaleCommon Stock 7,778 $55.82 $434,182.74
Disclosure

SEC source: 0001209191-17-030602 · doc4.xml · nonDerivative · entry 1

Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,319.24

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in ten (10) separate transactions with prices ranging from $55.80 to $55.89 for an average weighted sales price of $55.8219. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 05, 2017 Filed May 8, 2017 20:28 UTC
Kadre ManuelDirector
PurchaseCommon Stock 21,704 $55.79 $1,210,837.94
Disclosure

SEC source: 0001209191-17-030600 · doc4.xml · nonDerivative · entry 1

Kadre Manuel · CIK 0001396538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 111,255

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in seventy-four (74) separate transactions with prices ranging from $55.69 to $55.94 for an average weighted purchase price of $55.7887. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
March 15, 2017 Filed Mar 17, 2017 20:23 UTC
Andreano Dominic JSVP, General Counsel and Secy
SaleCommon Stock 6,517 $70.84 $461,645.38
Disclosure

SEC source: 0001209191-17-021381 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,229.22

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in twenty-four (24) separate transactions with prices ranging from $70.69 to $70.96 for an average weighted sales price of $70.8371. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 23, 2017 Filed Feb 24, 2017 21:31 UTC
SOSA ENRIQUEDirector
Exercise / conversionStock Options (Right to Buy) · Derivative 10,668 $32.33 Strike: $32.33 $344,843.10
Disclosure

SEC source: 0001209191-17-014340 · doc4.xml · derivative · entry 3

SOSA ENRIQUE · CIK 0001219818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,668 shares

Expires 2017-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 23, 2017 Filed Feb 24, 2017 21:31 UTC
SOSA ENRIQUEDirector
SaleCommon Stock 10,668 $69.65 $743,060.34
Disclosure

SEC source: 0001209191-17-014340 · doc4.xml · nonDerivative · entry 2

SOSA ENRIQUE · CIK 0001219818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,255

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in twenty-six (26) separate transactions with prices ranging from $69.49 to $69.74 for an average weighted sales price of $69.6532. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 23, 2017 Filed Feb 24, 2017 21:31 UTC
SOSA ENRIQUEDirector
Exercise / conversionCommon Stock 10,668 $32.33 $344,843.10
Disclosure

SEC source: 0001209191-17-014340 · doc4.xml · nonDerivative · entry 1

SOSA ENRIQUE · CIK 0001219818 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,923

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 17, 2017 Filed Feb 17, 2017 21:36 UTC
Lopez-Blanco VivianChief Financial Officer
SaleCommon Stock 15,164 $70.01 $1,061,605.86
Disclosure

SEC source: 0001209191-17-012145 · doc4.xml · nonDerivative · entry 1

Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,097.24

F1 · price: The price reported in Column 4 is an weighted average price. These shares were sold in seven separate transactions with prices ranging from $70.00 to $70.03 for an average weighted sales price of $70.0083. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 16, 2017 Filed Feb 17, 2017 21:31 UTC
Pepia John CPrincipal Accounting Officer
Exercise / conversionStock Options (Right to Buy) · Derivative 2,500 $28.55 Strike: $28.55 $71,362.50
Disclosure

SEC source: 0001209191-17-012120 · doc4.xml · derivative · entry 4

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500 shares

Expires 2017-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2017 Filed Feb 17, 2017 21:31 UTC
Pepia John CPrincipal Accounting Officer
SaleCommon Stock 1,500 $69.58 $104,371.50
Disclosure

SEC source: 0001209191-17-012120 · doc4.xml · nonDerivative · entry 3

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,525

F1 · balance_after: Includes 9,143 shares that were acquired by Reporting Person through Issuer's Employee Stock Purchase Plan.

Read SEC document
February 16, 2017 Filed Feb 17, 2017 21:31 UTC
Pepia John CPrincipal Accounting Officer
SaleCommon Stock 1,000 $69.58 $69,581.20
Disclosure

SEC source: 0001209191-17-012120 · doc4.xml · nonDerivative · entry 2

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,025

Read SEC document
February 16, 2017 Filed Feb 17, 2017 21:31 UTC
Pepia John CPrincipal Accounting Officer
Exercise / conversionCommon Stock 2,500 $28.55 $71,362.50
Disclosure

SEC source: 0001209191-17-012120 · doc4.xml · nonDerivative · entry 1

Pepia John C · CIK 0001674717 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,025

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2017 Filed Feb 17, 2017 21:31 UTC
GABOS PAUL GDirector
Exercise / conversionStock Options (Right to Buy) · Derivative 10,668 $27.72 Strike: $27.72 $295,663.62
Disclosure

SEC source: 0001209191-17-012117 · doc4.xml · derivative · entry 5

GABOS PAUL G · CIK 0001216803 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,668 shares

Expires 2018-05-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2017 Filed Feb 17, 2017 21:31 UTC
GABOS PAUL GDirector
Exercise / conversionStock Options (Right to Buy) · Derivative 10,668 $32.33 Strike: $32.33 $344,843.10
Disclosure

SEC source: 0001209191-17-012117 · doc4.xml · derivative · entry 4

GABOS PAUL G · CIK 0001216803 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,668 shares

Expires 2017-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2017 Filed Feb 17, 2017 21:31 UTC
GABOS PAUL GDirector
SaleCommon Stock 21,336 $69.63 $1,485,664.08
Disclosure

SEC source: 0001209191-17-012117 · doc4.xml · nonDerivative · entry 3

GABOS PAUL G · CIK 0001216803 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,255

F1 · price: The price reported in Column 4 is an weighted average price. These shares were sold in thirty-three (33) separate transactions with prices ranging from $69.4250 to $69.78 for an average weighted sales price of $69.6318. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 16, 2017 Filed Feb 17, 2017 21:31 UTC
GABOS PAUL GDirector
Exercise / conversionCommon Stock 10,668 $27.72 $295,663.62
Disclosure

SEC source: 0001209191-17-012117 · doc4.xml · nonDerivative · entry 2

GABOS PAUL G · CIK 0001216803 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,591

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2017 Filed Feb 17, 2017 21:31 UTC
GABOS PAUL GDirector
Exercise / conversionCommon Stock 10,668 $32.33 $344,843.10
Disclosure

SEC source: 0001209191-17-012117 · doc4.xml · nonDerivative · entry 1

GABOS PAUL G · CIK 0001216803 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,923

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2017 Filed Feb 17, 2017 21:30 UTC
Andreano Dominic JSVP, General Counsel and Secy
Exercise / conversionStock Options (Right to Buy) · Derivative 6,000 $28.55 Strike: $28.55 $171,270.00
Disclosure

SEC source: 0001209191-17-012112 · doc4.xml · derivative · entry 3

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,000 shares

Expires 2017-06-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2017 Filed Feb 17, 2017 21:30 UTC
Andreano Dominic JSVP, General Counsel and Secy
SaleCommon Stock 6,000 $69.59 $417,531.00
Disclosure

SEC source: 0001209191-17-012112 · doc4.xml · nonDerivative · entry 2

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,746.22

F1 · price: The price reported in Column 4 is a weighted average sales price. These shares were sold in twenty (20) separate transactions with prices ranging from $69.50 to $69.72 for a weighted average sales price of $69.5885. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 16, 2017 Filed Feb 17, 2017 21:30 UTC
Andreano Dominic JSVP, General Counsel and Secy
Exercise / conversionCommon Stock 6,000 $28.55 $171,270.00
Disclosure

SEC source: 0001209191-17-012112 · doc4.xml · nonDerivative · entry 1

Andreano Dominic J · CIK 0001549694 · SVP, General Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,746.22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 13, 2017 Filed Jun 2, 2017 20:43 UTC
MEDEL ROGER MDDirector · Chief Executive Officer
GiftCommon Stock 16,020 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-037322 · doc4.xml · nonDerivative · entry 1

MEDEL ROGER MD · CIK 0001093125 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,233,304

F1 · shares: Disposition pursuant to a gift to a charitable institute.

Read SEC document
February 10, 2017 Filed Feb 13, 2017 21:50 UTC Exercise / conversionStock Options (Right to Buy) · Derivative 8,280 $36.25 Strike: $36.25 $300,150.00
Disclosure

SEC source: 0001209191-17-010046 · doc4.xml · derivative · entry 9

Goldschmidt, MD Pascal J · CIK 0001356123 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,280 shares

Expires 2021-05-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2017 Filed Feb 13, 2017 21:50 UTC Exercise / conversionStock Options (Right to Buy) · Derivative 9,922 $29.36 Strike: $29.36 $291,260.31
Disclosure

SEC source: 0001209191-17-010046 · doc4.xml · derivative · entry 8

Goldschmidt, MD Pascal J · CIK 0001356123 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,922 shares

Expires 2020-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2017 Filed Feb 13, 2017 21:50 UTC Exercise / conversionStock Options (Right to Buy) · Derivative 10,668 $27.72 Strike: $27.72 $295,663.62
Disclosure

SEC source: 0001209191-17-010046 · doc4.xml · derivative · entry 7

Goldschmidt, MD Pascal J · CIK 0001356123 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,668 shares

Expires 2018-05-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2017 Filed Feb 13, 2017 21:50 UTC Exercise / conversionStock Options (Right to Buy) · Derivative 818 $32.33 Strike: $32.33 $26,441.85
Disclosure

SEC source: 0001209191-17-010046 · doc4.xml · derivative · entry 6

Goldschmidt, MD Pascal J · CIK 0001356123 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 818 shares

Expires 2017-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2017 Filed Feb 13, 2017 21:50 UTC SaleCommon Stock 25,294 $67.82 $1,715,317.67
Disclosure

SEC source: 0001209191-17-010046 · doc4.xml · nonDerivative · entry 5

Goldschmidt, MD Pascal J · CIK 0001356123 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,749

F1 · price: Sales of shares were made in thirty-three (33) separate transactions with prices ranging from $67.70 to $68.05 for an average weighted sales price of $67.8152.

Read SEC document
February 10, 2017 Filed Feb 13, 2017 21:50 UTC Exercise / conversionCommon Stock 8,280 $36.25 $300,150.00
Disclosure

SEC source: 0001209191-17-010046 · doc4.xml · nonDerivative · entry 4

Goldschmidt, MD Pascal J · CIK 0001356123 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,043

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2017 Filed Feb 13, 2017 21:50 UTC Exercise / conversionCommon Stock 9,922 $29.36 $291,260.31
Disclosure

SEC source: 0001209191-17-010046 · doc4.xml · nonDerivative · entry 3

Goldschmidt, MD Pascal J · CIK 0001356123 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,763

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2017 Filed Feb 13, 2017 21:50 UTC Exercise / conversionCommon Stock 10,668 $27.72 $295,663.62
Disclosure

SEC source: 0001209191-17-010046 · doc4.xml · nonDerivative · entry 2

Goldschmidt, MD Pascal J · CIK 0001356123 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,841

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2017 Filed Feb 13, 2017 21:50 UTC Exercise / conversionCommon Stock 818 $32.33 $26,441.85
Disclosure

SEC source: 0001209191-17-010046 · doc4.xml · nonDerivative · entry 1

Goldschmidt, MD Pascal J · CIK 0001356123 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,173

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2017 Filed Feb 15, 2017 22:04 UTC Amendment OtherCommon Stock 25,294 $67.82 $1,715,317.67
Disclosure

SEC source: 0001209191-17-011142 · doc4a.xml · nonDerivative · entry 1

Goldschmidt, MD Pascal J · CIK 0001356123 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,749

F1 · kind: Disposition of shares of Common Stock of the Issuer pursuant to a domestic relations order.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in thirty-three (33) separate transactions with prices ranging from $67.70 to $68.05 for an average weighted sales price of $67.8152. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 09, 2017 Filed Feb 10, 2017 21:56 UTC Exercise / conversionStock Options (Right to Buy) · Derivative 5,334 $32.33 Strike: $32.33 $172,421.55
Disclosure

SEC source: 0001209191-17-009613 · doc4.xml · derivative · entry 3

WALDEMAR, MD CARLO A · CIK 0001218839 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,334 shares

Expires 2017-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 09, 2017 Filed Feb 10, 2017 21:56 UTC SaleCommon Stock 5,334 $67.90 $362,186.07
Disclosure

SEC source: 0001209191-17-009613 · doc4.xml · nonDerivative · entry 2

WALDEMAR, MD CARLO A · CIK 0001218839 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,255

F1 · price: Sales of shares were made in seventeen (17) separate transactions with prices ranging from $67.83 to $68.00 for a weighted average sales price of $67.9014.

Read SEC document
February 09, 2017 Filed Feb 10, 2017 21:56 UTC Exercise / conversionCommon Stock 5,334 $32.33 $172,421.55
Disclosure

SEC source: 0001209191-17-009613 · doc4.xml · nonDerivative · entry 1

WALDEMAR, MD CARLO A · CIK 0001218839 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,589

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 17, 2017 Filed Jan 17, 2017 21:41 UTC
Lopez-Blanco VivianChief Financial Officer
SaleCommon Stock 10,000 $70.95 $709,500.00
Disclosure

SEC source: 0001209191-17-003876 · doc4.xml · nonDerivative · entry 1

Lopez-Blanco Vivian · CIK 0001479017 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,261.24

F1 · kind: Sales made pursuant to Reporting Person's 10b5-1 trading plan.

Read SEC document
December 07, 2016 Filed Dec 21, 2016 22:03 UTC PurchaseCommon Stock 2,100 $66.52 $139,681.50
Disclosure

SEC source: 0001209191-16-156355 · doc4.xml · nonDerivative · entry 1

Goldschmidt, MD Pascal J · CIK 0001356123 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,355

Read SEC document
November 10, 2016 Filed Nov 10, 2016 21:39 UTC
Kadre ManuelDirector
Exercise / conversionStock Options (Right to Buy) · Derivative 8,280 $36.25 Strike: $36.25 $300,150.00
Disclosure

SEC source: 0001209191-16-149372 · doc4.xml · derivative · entry 12

Kadre Manuel · CIK 0001396538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,280 shares

Expires 2021-05-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 10, 2016 Filed Nov 10, 2016 21:39 UTC
Kadre ManuelDirector
Exercise / conversionStock Options (Right to Buy) · Derivative 9,922 $29.36 Strike: $29.36 $291,260.31
Disclosure

SEC source: 0001209191-16-149372 · doc4.xml · derivative · entry 11

Kadre Manuel · CIK 0001396538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,922 shares

Expires 2020-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 10, 2016 Filed Nov 10, 2016 21:39 UTC
Kadre ManuelDirector
Exercise / conversionStock Options (Right to Buy) · Derivative 17,584 $18.91 Strike: $18.91 $332,513.44
Disclosure

SEC source: 0001209191-16-149372 · doc4.xml · derivative · entry 10

Kadre Manuel · CIK 0001396538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,584 shares

Expires 2019-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 10, 2016 Filed Nov 10, 2016 21:39 UTC
Kadre ManuelDirector
Exercise / conversionStock Options (Right to Buy) · Derivative 10,668 $27.72 Strike: $27.72 $295,663.62
Disclosure

SEC source: 0001209191-16-149372 · doc4.xml · derivative · entry 9

Kadre Manuel · CIK 0001396538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,668 shares

Expires 2018-05-23

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 10, 2016 Filed Nov 10, 2016 21:39 UTC
Kadre ManuelDirector
Exercise / conversionStock Options (Right to Buy) · Derivative 5,174 $32.33 Strike: $32.33 $167,249.55
Disclosure

SEC source: 0001209191-16-149372 · doc4.xml · derivative · entry 8

Kadre Manuel · CIK 0001396538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,174 shares

Expires 2017-11-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 10, 2016 Filed Nov 10, 2016 21:39 UTC
Kadre ManuelDirector
Exercise / conversionStock Options (Right to Buy) · Derivative 26,668 $29.40 Strike: $29.40 $784,039.20
Disclosure

SEC source: 0001209191-16-149372 · doc4.xml · derivative · entry 7

Kadre Manuel · CIK 0001396538 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 26,668 shares

Expires 2017-05-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.